Elke E Fröhlich-Reiterer1, Joachim Rosenbauer2, Susanne Bechtold-Dalla Pozza3, Sabine E Hofer4, Edith Schober5, Reinhard W Holl6. 1. Department of Paediatrics, Medical University of Graz, Graz, Austria. 2. Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany. 3. Department of Paediatrics, University Munich, Munich, Germany. 4. Department of Paediatrics, Medical University of Innsbruck, Innsbruck, Austria. 5. Department of Paediatrics, Medical University of Vienna, Vienna, Austria. 6. Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Abstract
OBJECTIVE: Increased weight gain has been reported prior to disease onset (accelerator hypothesis) and as a side effect of intensified insulin therapy in type 1 diabetes (T1D). Paediatric studies are complicated by the age-dependency and gender-dependency of BMI, and also by a trend towards obesity in the general population. The aim of this study was to evaluate factors related to the increase in BMI during the course of diabetes in children and adolescents with T1D in a large multicentre survey. DESIGN: Within the DPV database (Diabetespatienten Verlaufsdokumentation) a standardised, prospective, computer-based documentation programme, data of 53,108 patients with T1D, aged <20 years, were recorded in 248 centres. 12,774 patients (53% male, mean age 13.4±3.9, mean diabetes duration 4.7±3.0 years and mean age at diabetes onset 8.7±4.0 years) were included in this analysis. Population-based German reference data were used to calculate BMI-SDS and define overweight and obesity. RESULTS: 12.5% of T1D patients were overweight and 2.8% were obese. Multiple longitudinal regression analysis revealed that female gender, low BMI at diabetes onset, intensified insulin therapy and higher insulin dose, as well as pubertal diabetes onset, long diabetes duration and onset in earlier calendar years among girls, were related to higher BMI-SDS increase during the course of diabetes (p<0.01; all). CONCLUSIONS: Intensified insulin regimen is associated with weight gain during T1D treatment, in addition to demographic variables. Optimisation of diabetes management, especially in females, might limit weight gain in order to reduce overweight and obesity together with comorbidities among paediatric T1D patients. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: Increased weight gain has been reported prior to disease onset (accelerator hypothesis) and as a side effect of intensified insulin therapy in type 1 diabetes (T1D). Paediatric studies are complicated by the age-dependency and gender-dependency of BMI, and also by a trend towards obesity in the general population. The aim of this study was to evaluate factors related to the increase in BMI during the course of diabetes in children and adolescents with T1D in a large multicentre survey. DESIGN: Within the DPV database (Diabetespatienten Verlaufsdokumentation) a standardised, prospective, computer-based documentation programme, data of 53,108 patients with T1D, aged <20 years, were recorded in 248 centres. 12,774 patients (53% male, mean age 13.4±3.9, mean diabetes duration 4.7±3.0 years and mean age at diabetes onset 8.7±4.0 years) were included in this analysis. Population-based German reference data were used to calculate BMI-SDS and define overweight and obesity. RESULTS: 12.5% of T1D patients were overweight and 2.8% were obese. Multiple longitudinal regression analysis revealed that female gender, low BMI at diabetes onset, intensified insulin therapy and higher insulin dose, as well as pubertal diabetes onset, long diabetes duration and onset in earlier calendar years among girls, were related to higher BMI-SDS increase during the course of diabetes (p<0.01; all). CONCLUSIONS: Intensified insulin regimen is associated with weight gain during T1D treatment, in addition to demographic variables. Optimisation of diabetes management, especially in females, might limit weight gain in order to reduce overweight and obesity together with comorbidities among paediatric T1D patients. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Karl E Minges; Robin Whittemore; Stuart A Weinzimer; Melinda L Irwin; Nancy S Redeker; Margaret Grey Journal: Diabetes Res Clin Pract Date: 2017-02-04 Impact factor: 5.602
Authors: Kimberly A Driscoll; Karen D Corbin; David M Maahs; Richard Pratley; Franziska K Bishop; Anna Kahkoska; Korey K Hood; Elizabeth Mayer-Davis Journal: Curr Diab Rep Date: 2017-08 Impact factor: 4.810
Authors: Karl E Minges; Robin Whittemore; Ariana M Chao; Vanessa Jefferson; Kathryn M Murphy; Margaret Grey Journal: Diabetes Educ Date: 2016-06-13 Impact factor: 2.140
Authors: Anna R Kahkoska; Christina M Shay; Sarah C Couch; Jamie Crandell; Dana Dabelea; Evgenia Gourgari; Jean M Lawrence; Angela D Liese; Catherine Pihoker; Beth A Reboussin; Natalie The; Elizabeth J Mayer-Davis Journal: Pediatr Diabetes Date: 2018-09-14 Impact factor: 3.409
Authors: Belinda S Lennerz; Andrew P Koutnik; Svetlana Azova; Joseph I Wolfsdorf; David S Ludwig Journal: J Clin Invest Date: 2021-01-04 Impact factor: 14.808